Controlling the incidence of infection and malignancy by modifying immunosuppression.
about
Neoplastic disease after liver transplantation: Focus on de novo neoplasmsMinimally invasive approach to the repair of injured skeletal muscle with a shape-memory scaffold.The diagnostic yield and complications of open lung biopsies in kidney transplant patients with pulmonary disease.Human allograft rejection in humanized mice: a historical perspectiveA common gene signature across multiple studies relate biomarkers and functional regulation in tolerance to renal allograft.Hematopoietic chimerism and central tolerance created by peripheral-tolerance induction without myeloablative conditioning.Reconsidering the bio-detection of tolerance in renal transplantation.Viral infection: a potent barrier to transplantation tolerance.
P2860
Q26798306-EC722548-CEA6-4570-B08A-863710C2A750Q30650943-34625654-9588-4831-8AFD-001373932C2EQ30838236-B4CCB9BB-7174-4542-AE64-0CDA94606D9AQ33577374-73E7B684-A121-488E-A201-BBDE39BA6DDEQ35584849-055402A5-84AA-465B-97F8-D407EA7E3A5BQ35679173-AA1F72FF-1A5A-43D0-9517-B15D53F4AC4EQ36846202-03CFA4AA-8510-4005-9614-8BBBEC889BB6Q36876313-A7C6C0E0-99B1-404B-A88A-35F3AFD3FA57
P2860
Controlling the incidence of infection and malignancy by modifying immunosuppression.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Controlling the incidence of infection and malignancy by modifying immunosuppression.
@ast
Controlling the incidence of infection and malignancy by modifying immunosuppression.
@en
Controlling the incidence of infection and malignancy by modifying immunosuppression.
@nl
type
label
Controlling the incidence of infection and malignancy by modifying immunosuppression.
@ast
Controlling the incidence of infection and malignancy by modifying immunosuppression.
@en
Controlling the incidence of infection and malignancy by modifying immunosuppression.
@nl
prefLabel
Controlling the incidence of infection and malignancy by modifying immunosuppression.
@ast
Controlling the incidence of infection and malignancy by modifying immunosuppression.
@en
Controlling the incidence of infection and malignancy by modifying immunosuppression.
@nl
P1433
P1476
Controlling the incidence of infection and malignancy by modifying immunosuppression.
@en
P2093
P304
P433
P577
2001-12-01T00:00:00Z